fbpx

Our story

Only a little time has passed since we lost our beloved Simon, husband and father, to lung cancer and only those who had felt the breath of cancer on their face can understand the magnitude of pain we have been through.

Simon, 57 years old, fought an incredibly brave battle against this terrible disease, a battle that I dare say we fought together, each and every day and which unfortunately he lost leaving behind his two children, Melina and Eric.

I came to realize though during this time, that it wasn’t only lung cancer that we were fighting against. We seemed to be confronted by obstacles at the turn of every corner.

Although Simon received first class treatment throughout, I still feel incredibly frustrated by the thought that if we had followed a slightly different course of actions Simon might still be with us today. I keep thinking of everything that happened or should have happened and I can’t help but wondering for instance whether my husband would still be alive had he been administered an experimental drug found only in the US and only through clinical study.

Simon passed away on the 4th August 2020 at Metropolitan Hospital in Athens, overlooking the same sea, which as co-founder and shareholder of Fairseas Average Adjusters, had provided for him and his family so well since Simon had served the Shipping Industry for almost 40 years. And it was exactly then that all the people we were close to him decided that all this pain and all this valuable experience we so reluctantly acquired should not be in vain but should materialize into help and hope for similar patients.

Our goal is to create the 1st non-profit organization which will give every person the best chance in their fight against lung cancer. Early diagnosis, equal opportunities for access to innovative treatments, and participation in clinical trials will be just the beginning for FairLife Lung Cancer Care. Let us not forget that lung cancer is the leading cause of cancer death worldwide and unfortunately in Greece too. Yet, unlike other forms of cancer, it has not received the attention for prompt integration of recent scientific advances into daily practice, so that each patient can benefit. Early diagnosis, equal opportunities for access to innovative treatments, and participation in clinical trials will build the primary focus of FairLife Lung Cancer Care. Together we can make a difference.

Closing I would like to share with you Simon’s last words:

Help us make his wish come true!

With respect,
Family Simon Bell
Korina, Melina, Eric

*Simon Bell, Average Adjuster, has been active in Greece for almost 4 decades, with dedication in the field of shipping, with the last stop being the company “FairSeas Average Adjusters”, of which he was a co-founder and shareholder.

Any information provided on diseases is intended for the purpose of providing general information to the public and under no circumstances can it substitute the advice of a doctor or other competent health professional.